[Differentiated conservative treatment of ocular ischemic syndrome].
The efficiency of differentiated conservative treatment of ocular ischemic syndrome (OIS) was studied. In acute course, drugs improving bloodflow and blood rheology were prescribed. In patients with primary chronic pattern of the syndrome, drugs correcting microcirculation, transcapillary metabolism, and improving metabolism in ischemic tissues were used. After the treatment, visual acuity increased by at least 0.1 diopter in 12.8% patients with acute OIS, the peripheral visual field extended by 21.5% in 11.5%, and the function of the optic nerve improved in 10.5%. Comparative evaluation of results of therapy showed better efficiency in patients with the acute course.
Kiseleva
T N
TN
Tarasova
L N
LN
D000208:Acute Disease; D020757:Amaurosis Fugax / Q000628:therapy*; D005123:Eye / Q000098:blood supply*; D005260:Female; D006801:Humans; D007511:Ischemia / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D018917:Optic Neuropathy, Ischemic / Q000628:therapy*; D015356:Retinal Artery Occlusion / Q000628:therapy*; D013577:Syndrome; D014792:Visual Acuity; D014794:Visual Fields
Differentsirovannoe konservativnoe lechenie glaznogo ishemicheskogo sindroma.